August 02, 2019

Consulting Firm Advising Clients on Increasing Opioid Prescriptions

McKinsey & Company has received major criticisms for advising its client, Johnson & Johnson, to increase opioid prescriptions by “‘get[ting] more patients on higher doses of opioids’ and to study techniques ‘for keeping patients on opioids longer.’”  According to the New York Times, the state of Oklahoma used consulting records from McKinsey to build its case in its lawsuit  against  Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals.